Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
557,814
-
Shares change
-
-175,100
-
Total reported value, excl. options
-
$41,951,000
-
Value change
-
-$13,168,994
-
Number of sells
-
-8
-
Price
-
$75.21
Significant Holders of NOVOZYMES A S DKK 2.0 - COM as of Q2 2021
8 filings reported holding B798FW902 - NOVOZYMES A S DKK 2.0 - COM as of Q2 2021.
NOVOZYMES A S DKK 2.0 - COM has 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 557,814 shares
.
Largest 8 shareholders include SOMERVILLE KURT F (158,938 shares), Hemenway Trust Co LLC (133,123 shares), Broderick Brian C (83,264 shares), PUZO MICHAEL J (62,960 shares), Kidder Stephen W (53,330 shares), Page Arthur B (25,080 shares), Notis-McConarty Edward (24,452 shares), and Dempze Nancy E (16,667 shares).
This table shows the top 8 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.